These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14551059)

  • 1. Medium perfusion enables engineering of compact and contractile cardiac tissue.
    Radisic M; Yang L; Boublik J; Cohen RJ; Langer R; Freed LE; Vunjak-Novakovic G
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H507-16. PubMed ID: 14551059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density seeding of myocyte cells for cardiac tissue engineering.
    Radisic M; Euloth M; Yang L; Langer R; Freed LE; Vunjak-Novakovic G
    Biotechnol Bioeng; 2003 May; 82(4):403-14. PubMed ID: 12632397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities.
    Birla R; Dhawan V; Huang YC; Lytle I; Tiranathanagul K; Brown D
    Artif Organs; 2008 Sep; 32(9):684-91. PubMed ID: 18684210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electric field stimulation integrated into perfusion bioreactor for cardiac tissue engineering.
    Barash Y; Dvir T; Tandeitnik P; Ruvinov E; Guterman H; Cohen S
    Tissue Eng Part C Methods; 2010 Dec; 16(6):1417-26. PubMed ID: 20367291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oxygen on engineered cardiac muscle.
    Carrier RL; Rupnick M; Langer R; Schoen FJ; Freed LE; Vunjak-Novakovic G
    Biotechnol Bioeng; 2002 Jun; 78(6):617-25. PubMed ID: 11992527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac tissue engineering in an in vivo vascularized chamber.
    Morritt AN; Bortolotto SK; Dilley RJ; Han X; Kompa AR; McCombe D; Wright CE; Itescu S; Angus JA; Morrison WA
    Circulation; 2007 Jan; 115(3):353-60. PubMed ID: 17200440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function.
    Jackman C; Li H; Bursac N
    Acta Biomater; 2018 Sep; 78():98-110. PubMed ID: 30086384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile perfusion bioreactor for cardiac tissue engineering.
    Brown MA; Iyer RK; Radisic M
    Biotechnol Prog; 2008; 24(4):907-20. PubMed ID: 19194900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of oriented myocardium on three-dimensional micropatterned collagen-chitosan hydrogel.
    Chiu LL; Janic K; Radisic M
    Int J Artif Organs; 2012 Apr; 35(4):237-50. PubMed ID: 22505198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of regulatory factors on engineered cardiac tissue in vitro.
    Cheng M; Park H; Engelmayr GC; Moretti M; Freed LE
    Tissue Eng; 2007 Nov; 13(11):2709-19. PubMed ID: 17708718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel perfusion bioreactor providing a homogenous milieu for tissue regeneration.
    Dvir T; Benishti N; Shachar M; Cohen S
    Tissue Eng; 2006 Oct; 12(10):2843-52. PubMed ID: 17518653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of functional contractile cardiac tissues cultured in a perfusion system.
    Marsano A; Maidhof R; Tandon N; Gao J; Wang Y; Vunjak-Novakovic G
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():3590-3. PubMed ID: 19163485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue.
    Radisic M; Malda J; Epping E; Geng W; Langer R; Vunjak-Novakovic G
    Biotechnol Bioeng; 2006 Feb; 93(2):332-43. PubMed ID: 16270298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of substrate stiffness on the phenotype of heart cells.
    Bhana B; Iyer RK; Chen WL; Zhao R; Sider KL; Likhitpanichkul M; Simmons CA; Radisic M
    Biotechnol Bioeng; 2010 Apr; 105(6):1148-60. PubMed ID: 20014437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study of cardiac muscle tissue engineering in bioreactor].
    Liu X; Wang CY; Guo XM; OuYang WQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):7-12. PubMed ID: 12905598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system.
    Eschenhagen T; Fink C; Remmers U; Scholz H; Wattchow J; Weil J; Zimmermann W; Dohmen HH; Schäfer H; Bishopric N; Wakatsuki T; Elson EL
    FASEB J; 1997 Jul; 11(8):683-94. PubMed ID: 9240969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties.
    Bursac N; Papadaki M; White JA; Eisenberg SR; Vunjak-Novakovic G; Freed LE
    Tissue Eng; 2003 Dec; 9(6):1243-53. PubMed ID: 14670112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perfusion improves tissue architecture of engineered cardiac muscle.
    Carrier RL; Rupnick M; Langer R; Schoen FJ; Freed LE; Vunjak-Novakovic G
    Tissue Eng; 2002 Apr; 8(2):175-88. PubMed ID: 12031108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue engineering of a differentiated cardiac muscle construct.
    Zimmermann WH; Schneiderbanger K; Schubert P; Didié M; Münzel F; Heubach JF; Kostin S; Neuhuber WL; Eschenhagen T
    Circ Res; 2002 Feb; 90(2):223-30. PubMed ID: 11834716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Kit+ bone marrow stem cells differentiate into functional cardiac myocytes.
    Kubo H; Berretta RM; Jaleel N; Angert D; Houser SR
    Clin Transl Sci; 2009 Feb; 2(1):26-32. PubMed ID: 20443864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.